What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Liposome, Biophysics, Vesicle, Pharmacology and Chromatography.
His Liposome research is multidisciplinary, relying on both Pharmacokinetics, Phospholipid, Phosphatidylcholine, Doxorubicin and Lipid bilayer.
The Biophysics study combines topics in areas such as In vitro, Cationic liposome, Membrane, Ammonium sulfate and Cationic polymerization.
His research integrates issues of Absorbance, Analytical chemistry, Microviscosity, Fluorescence and Bilayer in his study of Vesicle.
His Pharmacology research focuses on Drug and Drug carrier.
He has researched Chromatography in several fields, including Dipalmitoylphosphatidylcholine, Aqueous two-phase system, Chemical engineering and Lamellar structure.
His most cited work include:
- Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. (1100 citations)
- Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. (212 citations)
- Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery☆ (189 citations)
What are the main themes of his work throughout his whole career to date?
Yechezkel Barenholz mostly deals with Liposome, Pharmacology, Biochemistry, Chromatography and Biophysics.
The concepts of his Liposome study are interwoven with issues in Pharmacokinetics, Phosphatidylcholine, Vesicle, Doxorubicin and Drug.
The Phosphatidylcholine study which covers Lipid bilayer that intersects with Bilayer.
His research investigates the connection between Pharmacology and topics such as In vivo that intersect with problems in In vitro.
His research ties Hydrolysis and Chromatography together.
His Biophysics research focuses on Cationic liposome and how it relates to DNA.
He most often published in these fields:
- Liposome (48.24%)
- Pharmacology (18.70%)
- Biochemistry (16.53%)
What were the highlights of his more recent work (between 2011-2021)?
- Liposome (48.24%)
- Pharmacology (18.70%)
- Drug delivery (6.78%)
In recent papers he was focusing on the following fields of study:
Liposome, Pharmacology, Drug delivery, Drug and Nanotechnology are his primary areas of study.
Yechezkel Barenholz has included themes like Biodistribution, Nanoparticle, Biophysics, Doxorubicin and Membrane in his Liposome study.
As part of the same scientific family, Yechezkel Barenholz usually focuses on Doxorubicin, concentrating on Tumor microenvironment and intersecting with Pegylated Liposomal Doxorubicin.
His Pharmacology study combines topics in areas such as In vitro and Complement system, Pseudoallergy.
His Drug carrier study in the realm of Drug delivery connects with subjects such as Amphiphile.
Yechezkel Barenholz works mostly in the field of Drug, limiting it down to topics relating to Distribution and, in certain cases, Biomedical engineering.
Between 2011 and 2021, his most popular works were:
- Nanomedicines: addressing the scientific and regulatory gap (179 citations)
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. (132 citations)
- Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles. (104 citations)
In his most recent research, the most cited papers focused on:
Yechezkel Barenholz focuses on Pharmacology, Liposome, Drug delivery, Drug and Nanotechnology.
His Pharmacology study incorporates themes from Immunology, In vitro and Complement system, Pseudoallergy.
His Liposome research is multidisciplinary, incorporating elements of Pharmacokinetics, Biodistribution, Quantitative structure–activity relationship, Doxorubicin and Biological system.
His studies deal with areas such as Membrane, Polymer, Nanomedicine and Microbiology as well as Drug delivery.
In his research on the topic of Membrane, Stereochemistry is strongly related with Ammonium.
His Drug study integrates concerns from other disciplines, such as Anticoagulant, Cytokine secretion, In vitro toxicology and Heparin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
